Reorganization of Active Surveillance of Acute Flaccid Paralysis (AFP) in Emilia-Romagna, Italy: a two-step Public Health intervention.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
10 04 2020
10 04 2020
Historique:
received:
20
03
2020
accepted:
23
03
2020
entrez:
11
4
2020
pubmed:
11
4
2020
medline:
30
3
2021
Statut:
epublish
Résumé
The International Health Regulations Emergency Committee declared in 2014 that poliovirus circulation is a public health emergency of international concern. In 2017 and 2018 Italy was classified at intermediate risk of poliovirus reintroduction based on suboptimal poliovirus surveillance. Acute flaccid paralysis active surveillance is the gold standard in the polio eradication process. The aims of this study were to investigate the causes of reduced acute flaccid paralysis case reporting in Emilia-Romagna in the last few years (step 1) and to study a public health intervention to restore an adequate level of acute flaccid paralysis surveillance in that region (step 2). In the first step a context analysis was performed by analysing the 2015-2017 Hospital Discharge Registers in Emilia-Romagna with the ICD-9-CM differential diagnosis codes for acute flaccid paralysis. Data from context analysis was then used to plan a new regional collaborative network of acute flaccid paralysis active surveillance. The active surveillance network was, at the end of the study, composed by 49 doctors from both hospital administrations and clinical wards from 4 University Hospitals and 7 Local Health Authorities throughout the Region. In 15 months, 7 acute flaccid paralysis cases have been reported; 85,7% received a full clinical and virological investigation and 83,3% completed the 60 day's follow-up. The mean response to each e-mail was 48,5% (SD 7,5%). In 2019, the Emilia-Romagna's active surveillance system reached the sensitivity, completeness of case investigation and follow-up required to achieve the minimum levels for certification standard surveillance.
Sections du résumé
BACKGROUND AND AIM OF THE WORK
The International Health Regulations Emergency Committee declared in 2014 that poliovirus circulation is a public health emergency of international concern. In 2017 and 2018 Italy was classified at intermediate risk of poliovirus reintroduction based on suboptimal poliovirus surveillance. Acute flaccid paralysis active surveillance is the gold standard in the polio eradication process. The aims of this study were to investigate the causes of reduced acute flaccid paralysis case reporting in Emilia-Romagna in the last few years (step 1) and to study a public health intervention to restore an adequate level of acute flaccid paralysis surveillance in that region (step 2).
METHODS
In the first step a context analysis was performed by analysing the 2015-2017 Hospital Discharge Registers in Emilia-Romagna with the ICD-9-CM differential diagnosis codes for acute flaccid paralysis. Data from context analysis was then used to plan a new regional collaborative network of acute flaccid paralysis active surveillance.
RESULTS
The active surveillance network was, at the end of the study, composed by 49 doctors from both hospital administrations and clinical wards from 4 University Hospitals and 7 Local Health Authorities throughout the Region. In 15 months, 7 acute flaccid paralysis cases have been reported; 85,7% received a full clinical and virological investigation and 83,3% completed the 60 day's follow-up. The mean response to each e-mail was 48,5% (SD 7,5%).
CONCLUSIONS
In 2019, the Emilia-Romagna's active surveillance system reached the sensitivity, completeness of case investigation and follow-up required to achieve the minimum levels for certification standard surveillance.
Identifiants
pubmed: 32275272
doi: 10.23750/abm.v91i3-S.9436
pmc: PMC7975913
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
85-91Références
Hum Vaccin Immunother. 2017 Feb;13(2):332-338
pubmed: 27929744
Am J Public Health. 2004 Mar;94(3):361-6
pubmed: 14998794
Euro Surveill. 2019 Apr;24(15):
pubmed: 30994104
BMC Public Health. 2019 Nov 15;19(1):1532
pubmed: 31730455
Acta Biomed. 2020 Apr 10;91(3-S):63-70
pubmed: 32275269
Ann Ist Super Sanita. 2016 Oct-Dec;52(4):469-471
pubmed: 27999213
Acta Biomed. 2010 Dec;81(1):40-6
pubmed: 20857852
BMJ. 2018 May 16;361:k1079
pubmed: 29769210
Ann Ig. 2013 Sep-Oct;25(5):427-33
pubmed: 24048181
Infect Genet Evol. 2018 Oct;64:57-64
pubmed: 29909243
Food Environ Virol. 2019 Dec;11(4):440-445
pubmed: 31346976
Hum Vaccin Immunother. 2015;11(1):277-81
pubmed: 25483546
Acta Biomed. 2019 Sep 13;90(9-S):28-34
pubmed: 31517887
Food Environ Virol. 2018 Dec;10(4):333-342
pubmed: 29948963
Acta Biomed. 2019 Sep 13;90(9-S):95-97
pubmed: 31517896
Zoonoses Public Health. 2018 Feb;65(1):114-123
pubmed: 28791803
Bull World Health Organ. 2004 Jan;82(1):24-30
pubmed: 15106297